Antimalarials
Antimalarials are used to treat malaria, a disease caused by protozoan parasites of the Plasmodium genus, which are transmitted by female Anopheles mosquitoes. Most of these compounds target the erythrocytic stage of the infection. Quinoline derivatives such as a chloroquine and mefloquine act by accumulating in the parasite food vacuole and inhibiting the biocrystallization of hemozoin, a breakdown product of hemoglobin, resulting in accumulation of cytotoxic heme. The action of Artemisinin, a Chinese herb, and its derivatives appears to involve the heme-mediated cleavage of endoperoxide bridges to produce free radicals.
Cat. No. | Product Name / Activity |
---|---|
6818 | Artemether |
Antimalarial; also inhibits neuroinflammation | |
6827 | Artesunate |
Antimalarial; suppresses ROS-induced activation of the NLRP3 inflammasome | |
4109 | Chloroquine diphosphate |
Antimalarial; inhibits apoptosis and autophagy | |
3387 | Gedunin |
Antimalarial; Hsp90 inhibitor | |
5648 | Hydroxychloroquine sulfate |
Antimalarial; autophagy inhibitor; also TLR9 inhibitor | |
7492 | Lomitapide mesylate |
Inhibits hemozoin formation in P.falciparum and growth of PfNF54 and Pf K1 strains | |
6856 | α-Mangostin |
Xanthone derivative; antimalarial | |
6819 | Mefloquine hydrochloride |
Antimalarial; inhibits protein synthesis in P falciparum; also gap channel blocker | |
7629 | Panobinostat |
Antimalarial; pan-histone deacetylase inhibitor |